Log In
Print this Print this

Familion LQTS test

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionPharmacogenetic test to identify mutation in people with inherited cardiac channelopathies such as Long QT syndrome (LQTS) and Brugada syndrome
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCardiovascular, Diagnostic
Indication DetailsDetect mutations in patients with LQTS and Brugada syndrome
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today